Results 281 to 290 of about 75,611 (308)
Some of the next articles are maybe not open access.

Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat.

Seminars in Diagnostic Pathology, 2019
The first reports of carbapenem resistance in Enterobacteriaceae isolates occurred in the early 1990s. Researchers published the first report of an isolate that produced Klebsiella pneumoniae carbapenemase in 2001.
Joseph D. Lutgring
semanticscholar   +3 more sources

Dissemination of blaNDM-5 via IncX3 plasmids in carbapenem-resistant Enterobacteriaceae among humans and in the environment in an intensive vegetable cultivation area in eastern China.

Environmental Pollution, 2021
The environment of a large-scale vegetable production area can be exposed to antibiotic residues and antibiotic-resistant bacteria (ARB) via animal manure and irrigation with contaminated water, which can facilitate the dissemination of ARB. However, the
Qian Zhao   +7 more
semanticscholar   +1 more source

Options for treating carbapenem-resistant Enterobacteriaceae

Current Opinion in Infectious Diseases, 2014
To address the therapeutic management of carbapenem-resistant Enterobacteriaceae on the basis of literature of the last 12 months.Retrospective and prospective (nonrandomized noncontrolled) studies provide data regarding the management of infections due to carbapenem-resistant Enterobacteriaceae.
Petros I, Rafailidis, Matthew E, Falagas
openaire   +2 more sources

Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients – insights on the risk of acquisition and CRE infection

Infectious Diseases, 2021
Background Kidney transplant recipients are a risk group for carbapenem-resistant Enterobacteriaceae infection. Objectives This study aimed to identify risk factors for CRE acquisition and infection among kidney transplant recipients.
M. Freire   +7 more
semanticscholar   +1 more source

Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections

Current Opinion in Infectious Diseases, 2018
Purpose of review In the absence of randomized clinical trial data, questions remain regarding the optimal treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections. CRE have historically been susceptible to polymyxins, tigecycline or aminoglycosides (mostly gentamicin), and these antibiotics have long been ...
Tumbarello M.   +2 more
openaire   +2 more sources

Resistance Mechanism of Carbapenem-Resistant Enterobacteriaceae to Quinolones

Clinical Laboratory, 2021
To investigate the epidemics of plasmid-mediated quinolone resistance (PMQR) gene in carbapenem-resistant Enterobacteriaceae (CRE) and the resistance mechanism.We collected CRE bacteria isolated clinically between December 2017 and December 2018 for identification and drug sensitivity testing using a VITEK2 Compact Analyzer.
Ming, Wei, Na, Tu, Kai, Yang
openaire   +2 more sources

The Emerging Threat From Carbapenem‐Resistant Enterobacteriaceae

Nursing for Women's Health, 2013
The emergence of carbapenem-resistant enterobacteriaceae (CRE) in the United States represents a serious danger to people who are hospitalized and is associated with case mortality rates as high as 50 percent. CRE infections have limited treatment options and the potential to spread widely if prevention and transmission measures are not employed ...
Jessica, Landry, Helen, Hurst
openaire   +2 more sources

Carbapenem-resistant bacteria over a wastewater treatment process: Carbapenem-resistant Enterobacteriaceae in untreated wastewater and intrinsically-resistant bacteria in final effluent

, 2021
Although urban wastewater treatment plants (UWWTPs) are important sites for antibiotic resistance elimination, their limitation in producing resistance-free effluents is recognized. Despite the critical importance of carbapenems to human health, the fate
S. Araújo   +8 more
semanticscholar   +1 more source

Outcomes of carbapenem-resistant Enterobacteriaceae isolation: Matched analysis

American Journal of Infection Control, 2014
Carbapenem-resistant Enterobacteriaceae (CRE) isolation is associated with poor outcomes. The matched cohort study design enables investigation of specific role of resistance in contributing to patients' outcomes. Patients with CRE were matched to 3 groups: (1) patients with extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL), (2 ...
Christopher, Bogan   +11 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy